Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company's wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.